Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged

Nicola Fossati, Massimo Lazzeri, Alexander Haese, Thomas McNicholas, Alexandre De La Taille, Nicolò Maria Buffi, Giovanni Lughezzani, Giulio Maria Gadda, Giuliana Lista, Alessandro Larcher, Alberto Abrate, Francesco Mistretta, Vittorio Bini, Joan Palou Redorta, Markus Graefen, Giorgio Guazzoni

Research output: Contribution to journalArticle

Abstract

Objectives To test the hypothesis that [-2]proPSA (p2PSA) and its derivatives are more accurate than total prostate-specific antigen (tPSA), free prostate-specific antigen (fPSA) and fPSA as percentage of tPSA (%fPSA) in detecting prostate cancer (PCa) in men aged

Original languageEnglish
Pages (from-to)913-920
Number of pages8
JournalBJU International
Volume115
Issue number6
DOIs
Publication statusPublished - Jun 1 2015

Keywords

  • p2PSA
  • predictive models
  • prostate biopsy
  • prostate health index
  • PSA
  • young men

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged'. Together they form a unique fingerprint.

  • Cite this

    Fossati, N., Lazzeri, M., Haese, A., McNicholas, T., De La Taille, A., Buffi, N. M., Lughezzani, G., Gadda, G. M., Lista, G., Larcher, A., Abrate, A., Mistretta, F., Bini, V., Redorta, J. P., Graefen, M., & Guazzoni, G. (2015). Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged . BJU International, 115(6), 913-920. https://doi.org/10.1111/bju.12718